• Accueil >
  • Publications >
  • Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions

Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directions

1 déc. 2019Journal for ImmunoTherapy of Cancer

DOI : 10.1186/s40425-019-0824-5

Auteurs

Marc Hilmi, Cindy Neuzillet, Julien Calderaro, Fouad Lafdil, Jean-Michel Pawlotsky, Benoit Rousseau